Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12

PURPOSE: This study was conducted to determine the effectiveness of immune checkpoint inhibitors (ICIs) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum-containing chemotherapy. We also identified clinical biomarkers which may be predictive of patient progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yun-Gyoo, Chang, Hyun, Keam, Bhumsuk, Chun, Sang Hoon, Park, Jihyun, Park, Keon Uk, Shin, Seong Hoon, An, Ho Jung, Lee, Kyoung Eun, Lee, Keun-Wook, Kim, Hye Ryun, Kim, Sung-Bae, Ahn, Myung-Ju, Hwang, In Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291197/
https://www.ncbi.nlm.nih.gov/pubmed/33285051
http://dx.doi.org/10.4143/crt.2020.824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291197/
https://www.ncbi.nlm.nih.gov/pubmed/33285051
http://dx.doi.org/10.4143/crt.2020.824

Ejemplares similares